89 FR 45 pgs. 16030-16031 - Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA LLC

Next Article Next

Type: NOTICEVolume: 89Number: 45Pages: 16030 - 16031

Docket number: [Docket No. DEA–1328]

FR document: [FR Doc. 2024–04747 Filed 3–5–24; 8:45 am]

Agency: Justice Department

Sub Agency: Drug Enforcement Administration

Official PDF Version: PDF Version

Pages: 16030, 16031

[top]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1328]

Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA LLC

AGENCY:

Drug Enforcement Administration, Justice.

ACTION:

Notice of application.

SUMMARY:

Sterling Pharma USA LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

DATES:

Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 6, 2024. Such persons may also file a written request for a hearing on the application on or before May 6, 2024.

ADDRESSES:

[top] The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission

of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.33(a), this is notice that on January 9, 2024, Sterling Pharma USA LLC., 10001 Sheldon Drive, Suite 101, Cary, North Carolina 27513, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):

Controlled substance	Drug code	Schedule
Tetrahydrocannabinols	7370	I
5-Methoxy-N-N-dimethyltryptamine	7431	I
Dimethyltryptamine	7435	I
Psilocybin	7437	I
Psilocyn	7438	I

The company plans to manufacture the above-listed controlled substance(s) to support clinical trials. No other activities for these drug codes are authorized for this registration.

Marsha Ikner,

Acting Deputy Assistant Administrator.

[FR Doc. 2024-04747 Filed 3-5-24; 8:45 am]

BILLING CODE P